Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
[en] OBJECTIVES: The purpose of the present study was to investigate retrospectively the relationship between botulinum toxin type A plus multidisciplinary rehabilitation and muscle echo intensity in post-stroke patients with spasticity. The primary aim was to investigate whether the effects of the intervention on the improvement of spasticity depend on muscle echo intensity, and the secondary aim was to investigate whether the motor function of the lower limbs depends on muscle echo intensity. METHODS: A 12-day inpatient protocol was designed for 102 post-stroke patients with spasticity due to lower limb paralysis. Muscle echo intensity of the triceps surae muscle was measured by ultrasonography, and the patients were categorized into four groups based on Heckmatt scale grades (Grades I-IV). RESULTS: All four groups classified by the Heckmatt scale showed significant pre-to-post-intervention differences in the knee and ankle modified Ashworth scale scores (p < 0.05). Grades I-III patient groups showed a significant improvement in lower limb motor function following intervention. Grade IV patients did not show a significant improvement in lower limb motor function. CONCLUSIONS: We observed significant improvements in the modified Ashworth scale scores after botulinum toxin type A and multidisciplinary rehabilitation therapy on post-stroke patients with spasticity. Although patients with lower muscle echo intensity demonstrated improvements in motor function, the improvement was poor in those with higher muscle echo intensity.
Disciplines :
Neurology
Author, co-author :
Hara, Takatoshi
Abo, Masahiro
Hara, Hiroyoshi
Kobayashi, Kazushige
Shimamoto, Yusuke
Shibata, Yamato
Sasaki, Nobuyuki
Yamada, Naoki
Niimi, Masachika ; Université de Liège - ULiège > Consciousness-Coma Science Group
Language :
English
Title :
Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Mayer NH. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl. 1997;6:S1–S13.
Sommerfeld DK, Eek EU, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35:134–139.
Watkins CL, Leathley MJ, Gregson JM, et al. Prevalence of spasticity post stroke. Clin Rehabil. 2002;16:515–522.
Kimura A, Abo M, Kawate N, et al. Efficacy and safety of botulinum toxin type a in treating upper limb spasticity in post-stroke patients: a multicenter, double-blind, Placebo-controlled Trial followed by an Open-label Trial. Japan J Rehabil Med. 2010;47:714–727.
Kimura A, Abo M, Kawate N, et al. Efficacy and safety of botulinum toxin type A in treating lower limb spasticity in post-stroke patients: a multicenter, double-blind, Placebo-controlled Trial followed by an Open-label Trial. Japan J Rehabil Med. 2010;47:626–636.
Burbaud P, Wiart L, Dubos JL, et al. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry. 1996;61:265–269.
Tanikawa H, Kagaya H, Saitoh E, et al. Efficacy of botulinum toxin A treatment for Pes Varus during gait. J Stroke Cerebrovasc Dis. 2015;24:2416–2422.
Elia AE, Filippini G, Calandrella D, et al. Botulinum neurotoxin for post-stroke spasticity in adults: a systematic review. Mov Disorders. 2009;24:801–812.
Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm. 2008;115:617–623.
Simpson DM, Gracies JM, Graham HK, et al. Therapeutics and technology assessment subcommittee of the American Academy of Neurology: assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review) report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2008;70:1691–1698.
Foley N, Murie-Fernandez M, Speechley M, et al. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis. Eur J Neurol. 2010;17:1419–1427.
Hara T, Abo M, Hara H, et al. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients. Int J Neurosci. 2016;27:1–10.
Santamato A, Micello MF, Panza F, et al. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. J Neurol Sci. 2014;347:39–43.
Kwon JY, Hwang JH, Kim JS. Botulinum toxin A injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report. Am J Phys Med Rehabil. 2010;89:279–286.
Pillen S, van Keimpema M, Nievelstein RA, et al. Skeletal muscle ultrasonography: visual versus quantitative evaluation. Ultrasound Med Biol. 2006;32:1315–1321.
Picelli A, Bonetti P, Fontana C, et al. Is spastic muscle echo intensity related to the response to botulinum toxin type A in patients with stroke? A cohort study. Arch Phys Med Rehabil. 2012;93:1253–1258.
Yamamoto S, Fuchi M, Yasui T. Change of rocker function in the gait of stroke patients using an ankle foot orthosis with an oil damper: immediate changes and the short-term effects. Prosthet Orthot Int. 2011;35:350–359.
Ohata K, Yasui T, Tsuboyama T, et al. Effects of an ankle-foot orthosis with oil damper on muscle activity in adults after stroke. Gait Post. 2011;33:102–107.
Sheean G, Lannin NA, Turner-Stokes L, et al. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol. 2010;17:74–93.
Picelli A, Lobba D, Midiri A, et al. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques. Clin Rehabil. 2014;3:232–242.
Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206–207.
Duncan PW, Weiner DK, Chandler J, et al. Functional reach: a new clinical measure of balance. J Gerontol. 1990;45:M192–M197.
Ikai T, Tatsuno H, Miyano S. Relationship between walking ability and balance function. Jpn J Rehabil Med. 2006;43:828–833.
Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–148.
Bischoff HA, Conzelmann M, Lindemann D, et al. Self-reported exercise before age 40: influence on quantitative skeletal ultrasound and fall risk in the elderly. Arch Phys Med Rehabil. 2001;82:801–806.
Yang EJ, Rha DW, Yoo JK, et al. Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch Phys Med Rehabil. 2009;90:741–744.
Heckmatt JZ, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr. 1982;5:656–660.
Gracies JM. Pathophysiology of spastic paresis. I: paresis and soft tissue changes. Muscle Nerve. 2005;31:535–551.
Picelli A, Tamburin S, Cavazza S, et al. Relationship between ultrasonographic, electromyographic, and clinical parameters in adult stroke patients with spastic equinus: an observational study. Arch Phys Med Rehabil. 2014;95:1564–1570.
Kinnear BZ, Lannin NA, Cusick A, et al. Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a systematic review. Phys Ther. 2014;94:1569–1581.
Johnson CA, Burridge JH, Strike PW, et al. The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation. Arch Phys Med Rehabil. 2004;85:902–909.
Hafsteinsdóttir TB, Rensink M, Schuurmans M. Clinimetric properties of the Timed Up and Go Test for patients with stroke: a systematic review. Top Stroke Rehabil. 2014;21:197–210.
Moore EJ, Banky M, Olver J, et al. The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: a systematic review. Brain Inj. 2015;29:676–687.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.